Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
1,08 USD | -6,09% | -23,94% | -6,90% |
Métier
Nombre d'employés: 18
Ventes par activité
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
New Drugs and Medical Devices
100,0
%
| 1 | 100,0 % | 0 | 100,0 % | -84,28% |
Ventes par région
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 1 | 100,0 % | 0 | 100,0 % | -84,28% |
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Chief Executive Officer | - | 23/06/23 | |
Leeds Chow
DFI | Director of Finance/CFO | 35 | 01/03/21 |
Eugene Jiang
CHM | Chairman | 38 | 01/07/15 |
Chief Tech/Sci/R&D Officer | 70 | - |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Yue Min Chung
BRD | Director/Board Member | 59 | 10/07/22 |
Shu Ling Chiang
BRD | Director/Board Member | 68 | - |
Eugene Jiang
CHM | Chairman | 38 | 01/07/15 |
Tsang Ming Jiang
BRD | Director/Board Member | 63 | 23/11/17 |
Norimi Sakamoto
BRD | Director/Board Member | 53 | 23/11/17 |
Yen-Hsin Chou
BRD | Director/Board Member | 43 | 23/11/17 |
Chief Tech/Sci/R&D Officer | 70 | - | |
Chang-Jen Jiang
BRD | Director/Board Member | 68 | - |
Yoshinobu Odaira
BRD | Director/Board Member | 76 | - |
Che-Wei Hsu
BRD | Director/Board Member | 43 | - |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 10 560 421 | 7 711 924 ( 73,03 %) | 0 | 73,03 % |
Coordonnées société
Secteur
Varia. 1 janv. | Capi. | |
---|---|---|
-6,90% | 11,38 M | |
+8,96% | 105 Md | |
-1,43% | 104 Md | |
+4,40% | 22,94 Md | |
-12,15% | 22,34 Md | |
-4,36% | 19,25 Md | |
-39,98% | 17,08 Md | |
-10,04% | 16,96 Md | |
+38,61% | 12,63 Md | |
+313,59% | 8,49 Md |
- Bourse
- Actions
- Action ABVC
- Société ABVC BioPharma, Inc.